Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers
- PMID: 31363933
- DOI: 10.1007/s40291-019-00413-1
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers
Abstract
In recent years, there has been a great deal of interest in the identification and validation of blood-based biomarkers for clinical use in chronic obstructive pulmonary disease (COPD). We now have panels of blood biomarkers that potentially hold great promise as they show statistically significant associations with COPD, but biomarkers for the diagnosis of COPD remain elusive. In fact, they are yet to demonstrate sufficient accuracy to be accepted in clinical use, and many are not specific to COPD but more related to inflammation (e.g. interleukin-6) or associated with other chronic diseases such as diabetes (e.g. soluble receptor for advanced glycation endproducts [sRAGE]). Although no single blood-based biomarker has demonstrated clinical utility for either the diagnosis or progression of COPD, it has been suggested that combinations of individual markers may provide important diagnostic or prognostic information; however, the interpretation of COPD biomarker results still requires thought and many questions remain unanswered.
Similar articles
-
Biomarkers for chronic obstructive pulmonary disease diagnosis and progression: insights, disappointments and promise.Curr Opin Pulm Med. 2019 Mar;25(2):144-149. doi: 10.1097/MCP.0000000000000549. Curr Opin Pulm Med. 2019. PMID: 30520743 Review.
-
Omics and the Search for Blood Biomarkers in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.Am J Respir Cell Mol Biol. 2019 Aug;61(2):143-149. doi: 10.1165/rcmb.2018-0245PS. Am J Respir Cell Mol Biol. 2019. PMID: 30874442 Free PMC article. Review.
-
Multiple biomarkers predict disease severity, progression and mortality in COPD.Respir Res. 2017 Jun 13;18(1):117. doi: 10.1186/s12931-017-0597-7. Respir Res. 2017. PMID: 28610627 Free PMC article.
-
Biomarkers in COPD.Clin Chest Med. 2014 Mar;35(1):131-41. doi: 10.1016/j.ccm.2013.09.006. Epub 2013 Dec 12. Clin Chest Med. 2014. PMID: 24507841 Review.
-
Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.Int J Chron Obstruct Pulmon Dis. 2017 Jul 7;12:2015-2021. doi: 10.2147/COPD.S138558. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28744116 Free PMC article.
Cited by
-
Chronic lung diseases: prospects for regeneration and repair.Eur Respir Rev. 2021 Jan 6;30(159):200213. doi: 10.1183/16000617.0213-2020. Print 2021 Mar 31. Eur Respir Rev. 2021. PMID: 33408088 Free PMC article. Review.
-
Inflammatory parameters and pulmonary biomarkers in smokers with and without chronic obstructive pulmonary disease (COPD).J Thorac Dis. 2021 Aug;13(8):4812-4829. doi: 10.21037/jtd-20-1580. J Thorac Dis. 2021. PMID: 34527321 Free PMC article.
-
Beyond Dual Bronchodilation - Triple Therapy, When and Why.Int J Chron Obstruct Pulmon Dis. 2022 Jan 14;17:165-180. doi: 10.2147/COPD.S345263. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35068929 Free PMC article.
-
Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans.Respir Res. 2022 Jan 24;23(1):15. doi: 10.1186/s12931-022-01934-w. Respir Res. 2022. PMID: 35073932 Free PMC article.
-
Single-nucleotide polymorphism rs2070600 regulates AGER splicing and the sputum levels of the COPD biomarker soluble receptor for advanced glycation end-products.ERJ Open Res. 2021 Jun 28;7(2):00947-2020. doi: 10.1183/23120541.00947-2020. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 34195255 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical